Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- Expectation of Unpleasant Events in Anxiety Disorders: Complete Statistical AnalysisIndependent statistical analysis of Expectation of Unpleasant Events in Anxiety Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00055224).
- EXPEDITEComplete statistical analysis of the EXPEDITE phase 3 trial comparing misoprostol vaginal insert with dinoprostone vaginal insert for reducing time to vaginal delivery during induction of labor.
- ExpeditionPROIndependent statistical analysis of A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.: Complete Statistical AnalysisIndependent statistical analysis of Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: Complete Statistical AnalysisIndependent statistical analysis of Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00752089).
- Expiratory Muscle Training in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Expiratory Muscle Training in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04569968).
- Exploration of Pupil Dilation in Horner’s Patients Taking Flomax: Complete Statistical AnalysisIndependent statistical analysis of Exploration of Pupil Dilation in Horner's Patients Taking Flomax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03615508).
- Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Exploratory Study for Toivoa-001 on Human Factors: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study for Toivoa-001 on Human Factors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06477913).
- Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Exploratory Study of OPC-12759 Ophthalmic Suspension: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study of OPC-12759 Ophthalmic Suspension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493180).
- Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD): Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01122849).
- EXPLOREIndependent statistical analysis of EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Exploring Life Experience and Lifestyle Intervention Program Among Patients With CKD: Complete Statistical AnalysisIndependent statistical analysis of Exploring Life Experience and Lifestyle Intervention Program Among Patients With CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exploring the Effects of Corticosteroids on the Human Hippocampus: Complete Statistical AnalysisIndependent statistical analysis of Exploring the Effects of Corticosteroids on the Human Hippocampus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03896659).
- Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures: primary endpoint results, effect estimate with…
- Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety: Complete Statistical AnalysisIndependent statistical analysis of Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00842946).
- ExRx in FAIndependent statistical analysis of NAD+ and Exercise in FA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04192136).
- EXSCELA detailed independent statistical analysis of EXSCEL, the phase 3 trial of exenatide once weekly versus placebo in patients with type 2 diabetes mellitus, including its randomized design, time-to-event endpoints, Cox models,…
- EXT-HFIndependent statistical analysis of Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EXTAXIndependent statistical analysis of Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- EXTENDIndependent statistical analysis of Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02725528).
- EXTENDIndependent statistical analysis of Exercise Effects on Brain Health and Learning From Minutes to Months: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EXTENDIndependent statistical analysis of Expanding Technology-Enabled Nurse Delivered Chronic Disease Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05120544).
- Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Extended Dosing With Eltrombopag for Severe Aplastic Anemia: Complete Statistical AnalysisIndependent statistical analysis of Extended Dosing With Eltrombopag for Severe Aplastic Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01891994).
- Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation: Complete Statistical AnalysisIndependent statistical analysis of Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02720536).
- Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children: Complete Statistical AnalysisIndependent statistical analysis of Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users: Complete Statistical AnalysisIndependent statistical analysis of Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Extending taVNS Paired With Infant CIMT Into a Home-Based Setting: Complete Statistical AnalysisIndependent statistical analysis of Extending taVNS Paired With Infant CIMT Into a Home-Based Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05857527).
- ExteNETIndependent statistical analysis of the phase 3 ExteNET trial of neratinib after adjuvant trastuzumab in women with early stage breast cancer, including randomized design, time-to-event endpoints, hazard ratios, confidence intervals, survival methodology,…
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Extension Study of IMO-8400 in Patients With Waldenström’s Macroglobulinemia Who Completed Study 8400-401: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study of MYL-1701P-3001 for Safety and Efficacy: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of MYL-1701P-3001 for Safety and Efficacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04674800).
- Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection: primary endpoint results, effect estimate with confidence interval, sample-size…
- Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.: primary endpoint results, effect estimate with confidence interval,…
- Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): primary endpoint…
- Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects: Complete Statistical AnalysisIndependent statistical analysis of Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects: primary endpoint results, effect estimate…
- Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038): Complete Statistical AnalysisIndependent statistical analysis of Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…